Influenza Market Research Reports & Industry Analysis
Influenza Industry Research & Market Reports
-
Global Avian Influenza Vaccines Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... growth of the Avian Influenza Vaccines industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Avian Influenza Vaccines. The report also introduces players ... Read More
-
Herpes Simplex Virus Treatment Market Report by Type (Herpes Simples Virus-1 Infection, Herpes Simplex Virus-2 Infection, and Others), Drug Type (Acyclovir, Valacyclovir, Famciclovir, and Others), Route of Administration (Oral, Injectable, Topical), Distribution Channel (Hospital Pharmacy, Drug Stores, Retail Stores, Online Pharmacy), and Region 2024-2032
... Drug Stores, Retail Stores, Online Pharmacy), and Region 2024-2032 The global herpes simplex virus treatment market size reached US$ 2.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.0 Billion ... Read More
-
Vaccines Market By Technology Type (Recombinant and Conjugate Vaccines, Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Others), By Indication (Pneumococcal Disease, Influenza, Human Papilloma Virus, Meningococcal Disease, Rotavirus, Varicella, Measles, Mumps, and Rubella, Diphtheria, Pertussis, and Tetanus (DTP), Polio, Hepatitis, Other Indications), By End User (Pediatric, Adults, Travelers): Global Opportunity Analysis and Industry Forecast, 2024-2035
... and Tetanus (DTP), Polio, Hepatitis, Other Indications), By End User (Pediatric, Adults, Travelers): Global Opportunity Analysis and Industry Forecast, 2024-2035 The vaccine market was valued at $43.2 billion in 2023 and is projected to reach ... Read More
-
Influenza Vaccine Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... 7.97 billion in 2023, and the market is now projected to grow from USD 8.55 billion in 2024 to USD 17.77 billion by 2032, exhibiting a CAGR of 9.6% during the forecast period of 2024-2032. ... Read More
-
Zika virus infection - Pipeline Insight, 2024
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Influenza Vaccines Market, By Vaccine Type (Inactivated, Live Attenuated), By Valency (Quadrivalent, Trivalent), By Route of Administration (Injection, Nasal Spray), By Age Group (Paediatrics, Adults), By Technology (Egg-Based Flu Vaccines, Cell Culture-Based Flu Vaccines, Recombinant Flu Vaccines), By Distribution Channel (Public, Private), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Flu Vaccines), By Distribution Channel (Public, Private), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Global influenza vaccines market is estimated to be valued at USD 8.30 BN in 2024 ... Read More
-
2024 Global Forecast for Influenza Diagnostics Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in 2025 ... Read More
-
Biological Safety Testing Market Size, Trends, Analysis, and Outlook By Product & Services (Consumables, Instrument, Services), By Application (Vaccine Development and Manufacturing, Monoclonal Antibodies Development and Manufacturing, Cellular & Gene Therapy Products Development and Manufacturing, Blood and Blood Products Development and Manufacturing, Others), By Test (Endotoxin Test, Sterility Test, Mycoplasma Tests, Bioburden Tests, Residual Host-cell Proteins & DNA Detection Tests, Virus safety Test, Others), by Region, Country, Segment, and Companies, 2024-2030
... Blood and Blood Products Development and Manufacturing, Others), By Test (Endotoxin Test, Sterility Test, Mycoplasma Tests, Bioburden Tests, Residual Host-cell Proteins & DNA Detection Tests, Virus safety Test, Others), by Region, Country, Segment, and Companies, ... Read More
-
Sexually Transmitted Diseases Treatment Market Size, Trends, Analysis, and Outlook By Disease (Gonorrhea, Syphilis, Herpes, Chlamydia, Hepatitis (HBV), Human Immunodeficiency Virus (HIV), Others), By Therapy (Anti-bacterial, Anti-viral, Vaccines, Anti-fungal), By Route of Administration (Oral, Injectable, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Sexually Transmitted Diseases Treatment market size is poised to register 4.09% growth (CAGR) from 2024 to ... Read More
-
West Nile Virus Therapeutics Market Size, Trends, Analysis, and Outlook By Product (Antivirals, Vaccines, Antibiotics, Analgesics, Others), By Route of Administration (Oral, Injectable, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... Country, Segment, and Companies, 2024-2030 The global West Nile Virus Therapeutics market size is poised to register 2.83% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The ... Read More
-
Travel Vaccines Market Size, Trends, Analysis, and Outlook By Disease (Influenza, Diptheria, Hepatitis, Typhoid, Others), By End-User (Adult vaccines, Pediatric vaccines), by Region, Country, Segment, and Companies, 2024-2030
... poised to register 9.79% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Travel Vaccines market By Disease (Influenza, Diptheria, Hepatitis, Typhoid, ... Read More
-
Influenza Diagnostics Market Size, Trends, Analysis, and Outlook By Test Type(RIDT, RT-PCR, Cell Culture, Others), by End userr(Hospitals, POCT, Laboratories), by Region, Country, Segment, and Companies, 2024-2030
... to register 7.4% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Influenza Diagnostics market across By Test Type(RIDT, RT-PCR, Cell Culture, Others), ... Read More
-
Infectious Vaccines Market Size, Trends, Analysis, and Outlook By Type (Inactivated Vaccines, Live Attenuated Vaccines, DNA and Recombinant Vector Vaccines, Others), By Disease(Typhoid, Tuberculosis, Tetanus and Diphtheria, Influenza, Hepatitis, Polio, Others), By Distribution Channel (Hospitals, Retail Pharmacies, Online Distribution), by Region, Country, Segment, and Companies, 2024-2030
... Retail Pharmacies, Online Distribution), by Region, Country, Segment, and Companies, 2024-2030 The global Infectious Vaccines market size is poised to register 6.3% growth from 2024 to 2030, presenting significant growth prospects for companies operating in ... Read More
-
Infectious Respiratory Disease Diagnostics Market Size, Trends, Analysis, and Outlook By Product (Instruments, Consumables, Services), By Sample Type (Saliva, Nasopharyngeal Swabs (NPS), Anterior Nasal Region, Blood, Others), By Application (COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Tuberculosis, Streptococcus Testing, Others), By Technology (Immunoassay, Molecular Diagnostics, Microbiology, Others), By End-User (Hospitals, Diagnostic Laboratories, Physician Offices, Others), by Region, Country, Segment, and Companies, 2024-2030
... Tuberculosis, Streptococcus Testing, Others), By Technology (Immunoassay, Molecular Diagnostics, Microbiology, Others), By End-User (Hospitals, Diagnostic Laboratories, Physician Offices, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Infectious Respiratory Disease Diagnostics market size is ... Read More
-
Neglected Tropical Diseases Drugs and Vaccines Market Size, Trends, Analysis, and Outlook By Disease (Malaria, Ebola, Dengue, Chagas, Leishmaniasis, Zika Virus), By Product (Drugs, Vaccines), by Region, Country, Segment, and Companies, 2024-2030
... Tropical Diseases Drugs and Vaccines market size is poised to register 4.9% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Neglected Tropical ... Read More
-
Influenza Medications Market Size, Trends, Analysis, and Outlook By Type (Antiviral Drugs, Antihistamines, Vaccines, Others), By Distribution Channel ( Hospital Pharmacy, Independent Pharmacy and Drug Store, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... The global Influenza Medications market size is poised to register 5.2% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Influenza Medications market ... Read More
-
Antiviral Drugs Market Size, Trends, Analysis, and Outlook By Type (Branded, Generics), By Class, DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Application (HIV, Hepatitis, Herpes, Influenza, Others), by Region, Country, Segment, and Companies, 2024-2030
... Application (HIV, Hepatitis, Herpes, Influenza, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Antiviral Drugs market size is poised to register 4.55% growth from 2024 to 2030, presenting significant growth prospects for companies ... Read More
-
Zoonotic Disease Treatment Market Size, Trends, Analysis, and Outlook By Type (Rabies, Tuberculosis, Malaria, Leishmaniasis, Ebola Virus Disease, Others), By Causative Agent (Bacteria, Virus, Nematode, Rodents, Ticks, Others), By Drug Class (Anti-fungal, Anti-bacterial, Antibiotics, Others), By Route of Administration (Oral, Topical, Others), By End-user (Hospitals, Specialty Clinics, Homecare, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), by Region, Country, Segment, and Companies, 2024-2030
... By Route of Administration (Oral, Topical, Others), By End-user (Hospitals, Specialty Clinics, Homecare, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Zoonotic Disease ... Read More
-
Infectious Disease Molecular Diagnostics Market Size, Trends, Analysis, and Outlook By Product & Service (Reagents, Kits, Consumables, Instruments, Software & Services), By Type of Testing (Laboratory Testing, PoC Testing), By Technology (Immunodiagnostics, Polymerase Chain Reaction, Clinical Microbiology, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-generation Sequencing, DNA Microarray, Others), By Disease Type (Hepatitis, HIV, Hospital-acquired Infections, Mosquito-borne Diseases, HPV, Chlamydia trachomatis, Neisseria gonorrhea, Tuberculosis, Influenza, Syphilis, Others), By Sample Type (Blood, Serum, and Plasma, Urine, Others), By End-User (Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes, Others), by Region, Country, Segment, and Companies, 2024-2030
... Clinical Microbiology, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-generation Sequencing, DNA Microarray, Others), By Disease Type (Hepatitis, HIV, Hospital-acquired Infections, Mosquito-borne Diseases, HPV, Chlamydia trachomatis, Neisseria gonorrhea, Tuberculosis, Influenza, Syphilis, Others), By Sample ... Read More
-
The 2025-2030 World Outlook for Human Influenza Vaccines
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Zika Virus Vaccines
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for H1N1 2009 Influenza Vaccines
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Influenza Medications
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Influenza Vaccines
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Influenza
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
Research Assistance
